Nasal delivery devices Market to Grow at a CAGR of 6.4% to reach US$ 95,676.62 Million from 2020 to 2027
The nasal delivery devices market is expected to reach US$ 95,676.62 million by 2027 from US$ 58,502.18 million in 2019. The market is estimated to grow with a CAGR of 6.4% from 2020 to 2027.
Nasal drug delivery is one of the most preferred drug delivery routes among patients as well as healthcare providers. This can majorly be attributed to the noninvasive nature of this route of delivery and greater drug absorbability through the nasal route. In addition, the nasal route offers a less hostile environment for drugs compared to the gastrointestinal route, thereby enabling better absorption of the drug. The easy administration of these drugs plays a crucial role in improving the compliance to drug therapies among patients, which in turn drives patient outcomes. Considering these factors, the preference for nasal drug delivery is increasing among patients as well as healthcare providers. Being highly vascular, nasal cavity enhances the drug absorption resulting in rapid action. The World Health Organization (WHO) has specific guidelines for manufacturers, which outlines all necessary requirements for the adoption of new nasal delivery devices with a single-use delivery system. Thus, nasal drug delivery, unlike other routes of drug delivery, does not require stringent sterile methods for administering drugs into the body. Thus, the high preference for nasal drug delivery among patients and health care providers, due to the growing awareness regarding its benefits, is driving the market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Nasal delivery devices Market: Strategic Insights
Market Size Value in US$ 58,502.18 Million in 2019 Market Size Value by US$ 95,676.62 Million by 2027 Growth rate CAGR of 6.4% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Nasal delivery devices Market: Strategic Insights
| Market Size Value in | US$ 58,502.18 Million in 2019 |
| Market Size Value by | US$ 95,676.62 Million by 2027 |
| Growth rate | CAGR of 6.4% from 2020-2027 |
| Forecast Period | 2020-2027 |
| Base Year | 2020 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Growing Prevalence of Respiratory and CNS Diseases
The initial proof-of-concept studies using novel nasal drug delivery devices showed promising results in the treatment of respiratory diseases, neurological disorders, and others. Drug delivery devices play an essential role in ensuring the delivery of entire drug to the target site in the nasal cavity. In the last few decades, several innovative drug delivery approaches have been introduced that might overcome the challenges involved in crossing the blood-brain barrier (BBB). Several scientific studies support the speculation that the delivery of drugs through the nasal route may allow higher concentrations of drugs to cross the BBB. The, rising incidence of neurological disorders would increase the demand for nasal delivery devices. According to the American Society of Clinical Oncology (ASCO), in 2020, ~3,540 brain and other CNS tumors have been diagnosed in children belonging to the age group of 0–14 years, in the US. The report also stated that the brain and other CNS tumors are the second most common cancers among children, accounting for ~26% of cancer cases in children with <15 years of age.
Respiratory conditions such as acute lower respiratory tract infections, tuberculosis, chronic obstructive pulmonary disease (COPD—a disease spectrum that includes bronchitis and emphysema), asthma, and lung cancer are among the most common causes of severe illnesses and deaths globally. Growing urbanization and pollution, unhealthy lifestyle and habits, and high tobacco smoking prevalence are among the factors leading to the surge in respiratory and cardiovascular disease cases. The respiratory could cause acute respiratory failure, treatment of which requires nasal drug delivery for continuous support. According to the Global Asthma Report 2018, published by Global Asthma Network, ~330 million people in the world are asthmatic. In addition, as per the estimates of Global Burden of Disease, a special research project by the Institute for Health Metrics and Evaluation, in 2016, ~420,000 died due to asthma. According to a study published in the US National Library of Medicine National Institutes of Health in 2018, the prevalence of asthma is consistently high in Korea, especially among female and elderly populations. Moreover, according to the Global Burden of Disease Study report, prevalence of COPD cases was 251 million in 2016. More than 90% of COPD deaths occur in low and middle-income countries (LMICs), and the disease is likely to become a leading cause of death in the world in the next 15 years.
Thus, the growing prevalence of respiratory diseases, neurological disorders, and other chronic diseases is boosting the demand for nasal delivery devices for effective drug delivery at the target sites.
Drug Type Insights
Based on drug type, the nasal delivery devices market is segmented into anesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines, and others. In 2019, the antihistamines segment accounted for the largest share of the market. Growth of this segment is attributed to increase in allergic rhinitis.
Delivery Technologies Insights
Based on delivery technologies, the global nasal delivery devices market is segmented into spray, nebulizers, inhalers, and others. In 2019, the inhalers segment held a major share of the market and is anticipated to register the highest CAGR in the market during the forecast period.
End User Insights
Based on end user, the global nasal delivery devices market is segmented into home care settings, hospitals, and clinics. In 2019, the home care settings segment held a major share of the market and is anticipated to register the highest CAGR in the market during the forecast period.
Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios to meet the growing consumer demand. The nasal delivery devices market players adopt the collaborations strategy to enlarge customer base worldwide, which also permits them to maintain their brand name globally.
Nasal delivery devices Market Report Scope
Nasal Delivery Devices Market – By Drug Type
- Anaesthetics
- Antibiotics
- Pain Relief Drugs
- Calcium Supplements
- Vasoconstrictors
- Antihistamines
- Others
Nasal Delivery Devices Market – By Delivery Technologies
- Spray
- Nebulizers
- Inhalers
- Others
Nasal Delivery Devices Market – By End User
- Home Care Settings
- Hospitals
- Clinics
Nasal Delivery Devices Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- South and Central America
- Brazil
- Argentina
- Rest of South America
Company Profiles
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc
- BD
- Sanofi
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy's Laboratories
- Neurelis, Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Type ; Delivery Technologies ; End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The nasal delivery devices market majorly consists of the players such as GlaxoSmithKline plc.,AstraZeneca, Pfizer Inc., BD, Sanofi, Merck & Co., Inc., Cadila Pharmaceuticals Ltd., Novartis AG, Dr. Reddy's Laboratories, and Neurelis. amongst others.
The factors that are driving growth of the market are growing prevalence of respiratory and cns diseases and increasing preference and awareness of intranasal drug delivery among patients.Moreover, strategic activities by the manufacturersare offering lucrative opportunities for the growth of the market.
Nasal drug delivery is one of the efficient route of drug administration. It offers needle-free drug delivery, optimal route for brain-targeted therapies, and superior bioavailability. Nasal route of administration is preferred in several disease indications such as Parkinson’s disease, prostate cancer, migraine, and influenza amongst others. Moreover, nasal route is also suitable for the treatment of drug addiction as well as for sedation.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Nasal Delivery Devices Market – By Drug Type
1.3.2 Global Nasal Delivery Devices Market – By Delivery Technologis
1.3.3 Global Nasal Delivery Devices Market – By End User
1.3.4 Global Nasal Delivery Devices Market – By Geography
2. Nasal Delivery Devices Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Nasal Delivery Devices Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America– PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific– PEST Analysis
4.2.4 Middle East & Africa
4.2.5 South and Central America
4.3 Expert Opinion
5. Nasal Delivery Devices Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Respiratory and CNS Diseases
5.1.2 Increasing Preference and Awareness Among Patients
5.2 Market Restraints
5.2.1 Challenges Associated with Nasal Administration of Drugs
5.3 Market Opportunities
5.3.1 Rising Adoption of Self-Administration Practices
5.4 Future Trends
5.4.1 Consolidation of Nasal Delivery Device Industry
5.5 Impact Analysis
6. Nasal Delivery Devices Market – Global Analysis
6.1 Global Nasal Delivery Devices Market Revenue Forecast And Analysis
6.2 Global Nasal Delivery Devices Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Nasal Delivery Devices Market Analysis – By Drug Type
7.1 Overview
7.2 Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)
7.3 Anesthetics
7.3.1 Overview
7.3.2 Anesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.4 Antibiotics
7.4.1 Overview
7.4.2 Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.5 Pain Relief Drugs
7.5.1 Overview
7.5.2 Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.6 Calcium Supplements
7.6.1 Overview
7.6.2 Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.7 Vasoconstrictors
7.7.1 Overview
7.7.2 Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.8 Antihistamines
7.8.1 Overview
7.8.2 Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
7.9 Others
7.9.1 Overview
7.9.2 Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8. Nasal Delivery Devices Market Analysis – By Delivery Technologies
8.1 Overview
8.2 Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)
8.3 Spray
8.3.1 Overview
8.3.2 Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8.4 Nebulizers
8.4.1 Overview
8.4.2 Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8.5 Inhalers
8.5.1 Overview
8.5.2 Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
9. Nasal Delivery Devices Market Analysis – By End -User
9.1 Overview
9.2 Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)
9.3 Home Care Setting
9.3.1 Overview
9.3.2 Home Care Setting: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Non-Invasive: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
9.5 Clinics
9.5.1 Overview
9.5.2 Clinics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
10. Nasal Delivery Devices Market – Geographic Analysis
10.1 North America: Nasal Delivery Devices Market
10.1.1 Overview
10.1.2 North America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.1.4 North America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.1.5 North America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.6 North America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
10.1.7 US: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.1.7.3 US Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 US Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.8 Canada: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.1.8.3 Canada Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 Canada Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.1.9 Mexico: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Nasal Delivery Devices Market
10.2.1 Overview
10.2.2 Europe: Nasal Delivery Devices Market - Revenue and Forecast to 2027 (USD Million)
10.2.3 Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.2.4 Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
10.2.5 Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.6 Europe: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
10.2.7 Germany: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.1 Germany: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.7.2 Germany Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.2.7.3 Germany Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.2.7.4 Germany Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.8 UK: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.1 UK: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.8.2 UK Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.2.8.3 UK Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.2.8.4 UK Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.9 France: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.1 France: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.9.2 France Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.2.9.3 France Nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)
10.2.9.4 France Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.10 Spain: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.1 Spain: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.10.2 Spain Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
10.2.10.3 Spain Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
10.2.10.4 Spain Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.11 Italy: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.1 Italy: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.11.2 Italy Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.2.11.3 Italy Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
10.2.11.4 Italy Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.2.12 Rest of Europe: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.1 Rest of Europe: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.2.12.2 Rest of Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.2.12.3 Rest of Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
10.2.12.4 Rest of Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Nasal Delivery Devices Market
10.3.1 Overview
10.3.1.1 Asia Pacific: Nasal Delivery Devices Market - Revenue and Forecast to 2027 (USD Million)
10.3.2 Asia Pacific: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.3 Asia Pacific: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.4 Asia Pacific: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.3.5 Asia Pacific: Nasal Delivery Devices Market, by Country, 2018 & 2027 (%)
10.3.6 China: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.6.1 China: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.6.2 China: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.6.3 China: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.6.4 China: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.3.7 Japan: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.1 Japan: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.7.2 Japan: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.7.3 Japan: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.7.4 Japan: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.3.8 India: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.1 India: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.8.2 India: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.8.3 India: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.8.4 India: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.3.9 South Korea: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.1 South Korea: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.9.2 South Korea: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.9.3 South Korea: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.9.4 South Korea: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.3.10 Australia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.1 Australia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.10.2 Australia: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.10.3 Australia: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.10.4 Australia: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.3.11 Rest of Asia-Pacific: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.1 Rest of Asia-Pacific: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.3.11.2 Rest of Asia-Pacific: Nasal Delivery Devices Market, by Drug Type, 2018–2027 (USD Million)
10.3.11.3 Rest of Asia-Pacific: Nasal Delivery Devices Market, by Delivery Technologies 2018–2027 (USD Million)
10.3.11.4 Rest of Asia-Pacific: Nasal Delivery Devices Market, by End User, 2018–2027 (USD Million)
10.4 Middle East & Africa: Nasal Delivery Devices Market
10.4.1 Overview
10.4.2 Middle East & Africa: Nasal Delivery Devices Market - Revenue and Forecast to 2027 (US$ Million)
10.4.3 Middle East & Africa Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.4.4 Middle East & Africa Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.4.5 Middle East & Africa Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.6 Middle East & Africa: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
10.4.7 Saudi Arabia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.1 Saudi Arabia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.7.2 Saudi Arabia Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.4.7.3 Saudi Arabia Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.4.7.4 Saudi Arabia Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
10.4.8 UAE: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.1 UAE: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.8.2 UAE Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.3 UAE Nasal Delivery Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
10.4.8.4 UAE Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.4.9 South Africa: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.1 South Africa: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.9.2 South Africa Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.4.9.3 South Africa Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.4.9.4 South Africa Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
10.4.10 Rest of Middle East and Africa: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.4.10.2 Rest of Middle East and Africa Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
10.4.10.3 Rest of Middle East and Africa Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.4.10.4 Rest of Middle East and Africa Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
10.5 South and Central America: Nasal Delivery Devices Market
10.5.1 Overview
10.5.2 South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.3 South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.5.4 South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.5.5 South and Central America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.6 South and Central America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
10.5.7 Brazil: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.1 Brazil: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.7.2 Brazil Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.5.7.3 Brazil Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.5.7.4 Brazil Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
10.5.8 Argentina: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.1 Argentina: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.8.2 Argentina Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.5.8.3 Argentina Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.5.8.4 Argentina Nasal Delivery Devices Market, by Mode – Revenue and Forecast to 2027 (USD Million)
10.5.9 Rest of South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.1 Rest of South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
10.5.9.2 Rest of South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
10.5.9.3 Rest of South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
10.5.9.4 Rest of South and Central America Nasal Delivery Devices Market, by End-User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Global Nasal Delivery Devices Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Nasal Delivery Devices Market– Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 GlaxoSmithKline plc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 AstraZeneca
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Pfizer Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Sanofi
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Merck & Co., Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Cadila Pharmaceuticals Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novartis AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Dr. Reddy's Laboratories
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Neurelis, Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary Of Terms
LIST OF TABLES
Table 1. North America Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)
Table 3. North America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 4. US Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 5. US Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 6. US Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. Canada Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Mexico Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Germany Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. UK Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 20. UK Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 21. UK Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 22. France Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 23. France Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 24. France Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 25. Spain Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 28. Italy Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 31. Rest of Europe Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 32. Rest of Europe Nasal Delivery Devices Market, by Delivery Technology – Revenue and Forecast to 2027 (USD Million)
Table 33. Rest of Europe Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific Nasal Delivery Devices Market, by Drug Type– Revenue and Forecast to 2027 (USD Million)
Table 35. Asia Pacific Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 36. Asia Pacific Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 37. China Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 38. China Nasal Delivery Devices Market, by Delivery Technologies– Revenue and Forecast to 2027 (USD Million)
Table 39. China Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 40. Japan Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 41. Japan Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 42. Japan Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 43. India Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 44. India Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 45. India Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 46. South Korea Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 47. South Korea Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 48. South Korea Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 49. Australia Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 50. Australia Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 51. Australia Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 52. Rest of Asia-Pacific Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 53. Rest of Asia-Pacific Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 54. Rest of Asia-Pacific Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 55. Middle East & Africa Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 56. Middle East & Africa Nasal Delivery Devices Market, by Delivery Technologies- Revenue and Forecast to 2027 (USD Million)
Table 57. Middle East and Africa Nasal Delivery Devices Market , by End User – Revenue and Forecast to 2027 (USD Million)
Table 58. Saudi Arabia Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 59. Saudi Arabia Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 60. Saudi Arabia Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
Table 61. UAE Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 62. UAE Nasal Delivery Devices Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 63. UAE Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 64. South Africa Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 65. South Africa Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 66. South Africa Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
Table 67. Rest of Middle East and Africa Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 68. Rest of Middle East and Africa Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Middle East and Africa Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027(USD Million)
Table 70. South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 71. South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 72. South and Central America Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 73. Brazil Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 74. Brazil Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 75. Brazil Nasal Delivery Devices Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 76. Argentina Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 77. Argentina Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 78. Argentina Nasal Delivery Devices Market, by Mode – Revenue and Forecast to 2027 (USD Million)
Table 79. Rest of South and Central America Nasal Delivery Devices Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)
Table 80. Rest of South and Central America Nasal Delivery Devices Market, by Delivery Technologies – Revenue and Forecast to 2027 (USD Million)
Table 81. Rest of South and Central America Nasal Delivery Devices Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 82. Organic Developments Done By Companies
Table 83. Inorganic Developments Done By Companies
Table 84. Glossary of Terms, Nasal Delivery Devices Market
LIST OF FIGURES
Figure 1. Nasal Delivery Devices Market Segmentation
Figure 2. Pharmaceutical Drug Delivery Segmentation, By Region
Figure 3. Nasal Delivery Devices Market Overview
Figure 4. Antihistamines Drug Type Segment Held Largest Share of Nasal Delivery Devices Market
Figure 5. APAC to Show Remarkable Growth During Forecast Period
Figure 6. Nasal Delivery Devices Market, by Geography (US$ Million)
Figure 7. Global Nasal Delivery Devices Market – Leading Country Markets (US$ Million)
Figure 8. Global Nasal Delivery Devices Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Nasal Delivery Devices Market Impact Analysis Of Driver And Restraints
Figure 15. Global Nasal Delivery Devices Market – Revenue Forecast And Analysis – 2019- 2027
Figure 16. Global Nasal Delivery Devices Market – By Geography Forecast and Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Nasal Delivery Devices Market
Figure 18. Nasal Delivery Devices Market Revenue Share, by Drug Type (2019 and 2027)
Figure 19. Anesthetics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Antibiotics: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Pain Relief Drugs: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Calcium Supplements: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Vasoconstrictors: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Antihistamines: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 25. Others: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Nasal Delivery Devices Market Revenue Share, by Delivery Technologies (2019 and 2027)
Figure 27. Spray: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Nebulizer: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Inhalers: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 31. Nasal Delivery Devices Market Revenue Share, by End -User (2019 and 2027)
Figure 32. Home Care Setting: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Non-Invasive: Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Clinics : Nasal Delivery Devices – Revenue and Forecast to 2027 (US$ Million)
Figure 35. North America: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 36. North America Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 37. North America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
Figure 38. US: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Canada: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 40. Mexico: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 41. Europe: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 42. Europe Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 43. Europe: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
Figure 44. Germany: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 45. UK: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 46. France: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 47. Spain: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 48. Italy: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 49. Rest of Europe: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 50. Asia Pacific: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 51. Asia Pacific Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 52. China: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 53. Japan: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 54. India: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 55. South Korea: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 56. Australia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 57. Rest of Asia-Pacific: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 58. Middle East & Africa: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 59. Middle East & Africa Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 60. Middle East & Africa: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
Figure 61. Saudi Arabia: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 62. UAE: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 63. South Africa: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 64. Rest of Middle East and Africa: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 65. South and Central America: Nasal Delivery Devices Market, by Key Country – Revenue (2019) (USD Million)
Figure 66. South and Central America Nasal Delivery Devices Market Revenue and Forecast to 2027 (USD Million)
Figure 67. South and Central America: Nasal Delivery Devices Market, by Country, 2019 & 2027 (%)
Figure 68. Brazil: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 69. Argentina: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 70. Rest of South and Central America: Nasal Delivery Devices Market – Revenue and Forecast to 2027 (USD Million)
Figure 71. Impact of COVID-19 Pandemic on Nasal Delivery Devices market in North American Countries
Figure 72. Impact of COVID-19 Pandemic on Nasal Delivery Devices market in European Countries
Figure 73. Impact of COVID-19 Pandemic on Nasal Delivery Devices market in Asia Pacific Countries
Figure 74. Impact of COVID-19 Pandemic on Nasal Delivery Devices market in Rest of the World
Figure 75. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Nasal delivery devices Market
- GlaxoSmithKline plc.
- AstraZeneca
- Pfizer Inc.
- BD
- Sanofi
- Merck & Co., Inc.
- Cadila Pharmaceuticals Ltd.
- Novartis AG
- Dr. Reddy's Laboratories
- Neurelis, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Nasal delivery devices Market
Oct 2020
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Oct 2020
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Oct 2020
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Oct 2020
Electronic Patient-Reported Outcomes (ePROS) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
Wellbeing Platform Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Wellbeing, and Others), Category (Fitness & Nutrition Consultant, Psychological Therapists, and Organization/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organization, and Homecare), and Geography
Oct 2020
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Get Free Sample For